title: Induction of inducible nitric oxide synthase expression in human secretory endometrium.
abstract: The endometrial secretory phase is characterized by stromal oedema, a premenstrual increase in stromal macrophages and an increased cytokine production as menstruation approaches. Nitric oxide (NO) is a mediator of vasodilatation and cytotoxicity which is synthesized from L-arginine by NO synthases (NOS). These enzymes are either constitutively expressed or induced by lipopolysaccharides and/or cytokines. The presence and function of the inducible isoform of NOS (iNOS) in normal human endometrium has not been fully elucidated until recently. Frozen tissue sections taken from 22 women who underwent hysterectomy and adnexectomy for benign disease were immunostained with antibodies raised against the different NOS isoforms to investigate the presence of NOS in human endometrium. iNOS stained positive in the glandular epithelial cells of the secretory endometrium. Staining was either weak or absent in the proliferative and inactive endometrium, as well as in the oviduct and the glandular epithelium of the endocervix. The stroma remained uniformly negative. Immunoreactivity for endothelial constitutive NOS (eNOS) was confined exclusively to endothelial cells. Furthermore, epithelial cells from endometrium, oviduct and endocervix and all endothelial cells showed positive staining for reduced nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase, which is a histochemical marker for NOS activity. Reverse transcriptase polymerase chain reaction (RT-PCR) was performed in order to assess the presence of NOS mRNA. Abundant expression of iNOS mRNA was detected in the secretory phase endometrium only. The strong expression of inducible NO synthase in human secretory phase endometrium suggests that the increased production of NO, probably induced by cytokines, may be relevant to the process of menstruation.
authors.affiliation: Department of Gynaecology and Obstetrics, University of Vienna, School of Medicine, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Tschugguel
authors.forename: C
authors.initials: C
authors.lastname: Schneeberger
authors.forename: G
authors.initials: G
authors.lastname: Unfried
authors.forename: K
authors.initials: K
authors.lastname: Czerwenka
authors.forename: W
authors.initials: W
authors.lastname: Weninger
authors.forename: M
authors.initials: M
authors.lastname: Mildner
authors.forename: J R
authors.initials: JR
authors.lastname: Bishop
authors.forename: J C
authors.initials: JC
authors.lastname: Huber
mesh_terms: D001483:Base Sequence; D017931:DNA Primers / Q000235:genetics; D004717:Endometrium / Q000033:anatomy & histology / Q000201:enzymology* / Q000378:metabolism; D004790:Enzyme Induction; D004848:Epithelium / Q000201:enzymology; D005260:Female; D005498:Follicular Phase / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008183:Luteal Phase / Q000378:metabolism; D008598:Menstruation / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000096:biosynthesis* / Q000235:genetics*; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
chemical_list: D017931:DNA Primers; D012333:RNA, Messenger; C496319:NOS2 protein, human; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III